- News Releases
-
- Jan. 06, 2021 (PDF/84KB)Products
- Myovant Sciences Announces U.S. Availability of ORGOVYX for the Treatment of Advanced Prostate Cancer
-
- Dec. 24, 2020 (PDF/93KB)Products
- Urovant Sciences Announces U.S. FDA Approval of GEMTESA (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
Other Notices
-
- Nov. 20, 2020Others
- Posted Factbook 2020 ver.2
-
- Sep. 30, 2020Others
- Posted Integrated Report 2020
-
- Jun. 30, 2020Others
- Posted Factbook 2020
IR Library
-
Continuing to challenge ourselves to support a healthy future for people
-
Aiming to create innovative pharmaceutical products
-
Targeting sustainable growth
-
Leading our global expansion